VERU insider trading
NasdaqCM HealthcareVERU INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About VERU INC.
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Company website: verupharma.com
VERU insider activity at a glance
FilingIQ has scored 153 insider transactions for VERU since Aug 23, 2017. The most recent filing in our index is dated May 4, 2026.
Across the full history, 82 open-market purchases
and 42 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VERU insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VERU?
- FilingIQ tracks 153 Form 4 insider transactions for VERU (VERU INC.), covering filings from Aug 23, 2017 onwards. 8 of those were filed in the last 90 days.
- Are VERU insiders net buyers or net sellers?
- Across the full Form 4 history for VERU, 82 transactions (54%) were open-market purchases and 42 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VERU insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VERU in?
- VERU INC. (VERU) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $34.83M.
Methodology & sources
Every VERU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.